Abstract:Lipid droplets (LD) have long been considered as mere fat drops; however, LD have lately been revealed to be ubiquitous, dynamic and to be present in diverse organelles in which they have a wide range of key functions. Although incompletely understood, the biogenesis of eukaryotic LD initiates with the synthesis of neutral lipids (NL) by enzymes located in the endoplasmic reticulum (ER). The accumulation of NL leads to their segregation into nanometric nuclei which then grow into lenses between the ER leaflets as they are further filled with NL. The lipid composition and interfacial tensions of both ER and the lenses modulate their shape which, together with specific ER proteins, determine the proneness of LD to bud from the ER toward the cytoplasm. The most important function of LD is the buffering of energy. But far beyond this, LD are actively integrated into physiological processes, such as lipid metabolism, control of protein homeostasis, sequestration of toxic lipid metabolic intermediates, protection from stress, and proliferation of tumours. Besides, LD may serve as platforms for pathogen replication and defense. To accomplish these functions, from biogenesis to breakdown, eukaryotic LD have developed mechanisms to travel within the cytoplasm and to establish contact with other organelles. When nutrient deprivation occurs, LD undergo breakdown (lipolysis), which begins with the LD-associated members of the perilipins family PLIN2 and PLIN3 chaperone-mediated autophagy degradation (CMA), a specific type of autophagy that selectively degrades a subset of cytosolic proteins in lysosomes. Indeed, PLINs CMA degradation is a prerequisite for further true lipolysis, which occurs via cytosolic lipases or by lysosome luminal lipases when autophagosomes engulf portions of LD and target them to lysosomes. LD play a crucial role in several pathophysiological processes. Increased accumulation of LD in non-adipose cells is commonly observed in numerous infectious diseases caused by intracellular pathogens including viral, bacterial, and parasite infections, and is gradually recognized as a prominent characteristic in a variety of cancers. This review discusses current evidence related to the modulation of LD biogenesis and breakdown caused by intracellular pathogens and cancer.

Application of Synthetic Lipid Droplets in Metabolic Diseases.

Roles of lipid droplets and related proteins in metabolic diseases

Lipid droplet biogenesis and functions in health and disease

Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases

Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions

Life-Inspired Endogenous Dynamic Behavior of Lipid Droplet-like Microcompartments in Artificial Adipocyte-like Structures

Lipid Droplets, the Central Hub Integrating Cell Metabolism and the Immune System

Molecular dynamics simulations of intracellular lipid droplets: a new tool in the toolbox

Synthetic Cells from Droplet-Based Microfluidics for Biosensing and Biomedical Applications

Lipid droplets: a cellular organelle vital in cancer cells

Lipophagy and Liver Disease: New Perspectives to Better Understanding and Therapy.

The biogenesis of lipid droplets: Lipids take center stage

Artificial Lipid Droplets: Novel Effective Biomaterials to Protect Cells against Oxidative Stress and Lipotoxicity

Lipid droplet-targeting optical biosensors: Design strategies and applications

Validating an artificial organelle: Studies of lipid droplet-specific proteins on adiposome platform

Lipid Droplets Big and Small: Basic Mechanisms That Make Them All

Lipid Droplets: Formation, Degradation, and Their Role in Cellular Responses to Flavivirus Infections

Recent advances in design and application of synthetic membraneless organelles

Synthesis of lipid membranes for artificial cells

Protein Quality Control and Lipid Droplet Metabolism

The Proteomics of Lipid Droplets: Structure, Dynamics, and Functions of the Organelle Conserved from Bacteria to Humans